AMBAL

Serial Number 75440571
606

Registration Progress

Application Filed
Feb 25, 1998
Under Examination
Apr 27, 1999
Approved for Publication
Jan 2, 1999
Published for Opposition
Feb 2, 1999
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: AMBAL
Previous Owner: NOVARTIS AG
Classes: 005

Trademark Image

AMBAL

Basic Information

Serial Number
75440571
Filing Date
February 25, 1998
Published for Opposition
February 2, 1999
Abandonment Date
June 29, 2002
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 28, 2002
Classes
005

Rights Holder

NOVARTIS AG

03
Address
4002 Basle
CH

Ownership History

NOVARTIS AG

Original Applicant
03
4002 Basle CH

NOVARTIS AG

Owner at Publication
03
4002 Basle CH

Legal Representation

Attorney
BARRY A SOLOMON

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

17 events
Date Code Type Description Documents
Jun 29, 2002 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 3, 2001 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 24, 2001 EXT5 S SOU EXTENSION 5 FILED Loading...
May 6, 2001 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 19, 2001 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 10, 2001 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 19, 2000 EXT3 S SOU EXTENSION 3 FILED Loading...
May 23, 2000 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 3, 2000 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 26, 1999 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 13, 1999 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 27, 1999 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 2, 1999 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 2, 1999 NPUB O NOTICE OF PUBLICATION Loading...
Nov 9, 1998 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 3, 1998 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Oct 13, 1998 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of central nervous system diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005